All In MedTech

Device Trial Radar · NCT00873106

Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography

Last checked: Nov 19, 2026Latest source record: Sep 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Feb 2009

Primary completion

Mar 2010

Study completion Mar 2010

Sponsor

Lead sponsor
Glostrup University Hospital, CopenhagenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 1, 2009

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the present study is to determine if the retinal thickness estimates of the Stratus OCT, the 3D OCT-1000, and the CirrusHD OCT are comparable in diabetic and in healthy individuals (OCT=Optical Coherence Tomography).

Conditions

  • Healthy
  • Diabetic Maculopathy

Interventions

  • Optical coherence tomographyDevice

    Stratus OCT: fast radial lines 3D OCT-1000: radial 2048 and 3D OCT Cirrus HD OCT: 3D OCT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Retinal thickness and retinal volume from each OCT scanTime frame: within 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Nordre Ringvej 57

    Glostrup Municipality, Copenhagen, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.